Journal article
Considerations for the definition of remission criteria in psoriatic arthritis
- Abstract:
-
Objectives
Psoriatic arthritis (PsA) is an autoimmune disease that can cause progressive structural damage of the joints and irreversible disability. The potentially achievable results of biologic therapy for PsA has led to the view that disease remission should be the goal of treatment. However, the heterogeneity of disease manifestations and need for validated outcome measures makes defining remission in PsA challenging. This article evaluates proposed criteria for defining rem...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 351.7KB)
-
- Publisher copy:
- 10.1016/j.semarthrit.2017.10.021
Authors
Funding
Novartis Pharmaceuticals Corporation
More from this funder
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Seminars in Arthritis and Rheumatism Journal website
- Volume:
- 47
- Issue:
- 6
- Pages:
- 786-796
- Publication date:
- 2017-10-31
- Acceptance date:
- 2017-10-31
- DOI:
- EISSN:
-
1532-866X
- ISSN:
-
0049-0172
- Pmid:
-
29566966
- Source identifiers:
-
832067
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:832067
- UUID:
-
uuid:8838bdcd-c45b-492c-b605-b39765753bcb
- Local pid:
- pubs:832067
- Deposit date:
- 2018-05-30
Terms of use
- Copyright holder:
- *Copyright holder name ("et al" as required)*
- Copyright date:
- 2017
- Notes:
- © 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
If you are the owner of this record, you can report an update to it here: Report update to this record